Lv11
90 积分 2024-06-29 加入
Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future
1小时前
待确认
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
2个月前
已完结
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
2个月前
已完结
Construction a novel osteoporosis model in immune-deficient mice with natural ageing
3个月前
已完结
Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
5个月前
已完结
BTK inhibitors enhance NKG2D ligand expression by regulating IL-10/STAT3 pathway in activated non-GCB diffuse large B-cell lymphoma cells
5个月前
已完结
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas
6个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
6个月前
已完结
皖公网安备34019202002308
